Get ready for more JABS: CDC shortens Pfizer COVID booster interval to five months

The Centers for Disease Control and Prevention (CDC) on Tuesday, January 4, cut the recommended interval between initial inoculation and boosting from six to five months for Americans who are fully vaccinated with Pfizer’s Wuhan coronavirus (COVID-19) vaccine. Booster interval recommendations for those who got Johnson & Johnson or Moderna remain at two and six months, respectively. The agency, which … Continue reading Get ready for more JABS: CDC shortens Pfizer COVID booster interval to five months

U.S. data show a steady rise in breakthrough infections among FULLY vaccinated people

The spread of the B16172 delta variant throughout the U.S. has caused a surge in breakthrough infections. Data from the Centers for Disease Control and Prevention‘s (CDC) latest weekly report confirm the increase in COVID-19 cases among fully vaccinated Americans. The newly released figures have strengthened calls from government scientists to push for booster shots to address the spread of the more infectious delta … Continue reading U.S. data show a steady rise in breakthrough infections among FULLY vaccinated people

Scientists warn push for COVID-19 booster shots not based on scientific data; “politics” and profits now driving vaccine policies

Scientists have spoken out against the White House’s decision to allow fully vaccinated Americans to get booster doses of the Wuhan coronavirus (COVID-19) vaccines. The White House recently announced on Wednesday, Aug. 18, that starting Sept. 20 everyone over the age of 18 who has been fully vaccinated with either the Pfizer-BioNTech or Moderna vaccines … Continue reading Scientists warn push for COVID-19 booster shots not based on scientific data; “politics” and profits now driving vaccine policies

Johnson & Johnson expects global sales of $2.5 billion from coronavirus vaccines in 2021

Johnson & Johnson expects to make $2.5 billion in global sales for 2021 from its single-dose Wuhan coronavirus (COVID-19) vaccine. The American firm’s July 21 remarks come following the release of its second-quarter earnings for the year – with favorable numbers. The projection follows concerns over its vaccine’s effectiveness against more infectious coronavirus strains. The company reported earnings and … Continue reading Johnson & Johnson expects global sales of $2.5 billion from coronavirus vaccines in 2021